Abstract:SUMMARY: Rheumatoid arthritis (RA), an inflammatory autoimmune disease that causes cartilage degradation and tissue destruction, can affect synovial joints such as the knee joint. The link between the nitrosative stress enzyme inducible nitric oxide synthase (iNOS) and the cytokine interleukin-1 (IL-1β) in RA-induced knee joint synovial membrane damage with and without the incorporation of the GSK3β inhibitor TDZD-8 has never been studied. As a result, we used active immunization method with collagen type II (COII) for twenty one days to induce RA in rats. TDZD-8 (1 mg/kg; i.p.) was given daily into matched immunized rats for three weeks after day 21 (COII+TDZD-8). Blood and tissue samples were taken 42 days after immunization. A dramatic increase in rheumatoid factor (RF) blood levels, as well as considerable synovial tissue damage and inflammatory cell infiltration of the synovial membrane, were used to validate the onset of RA following COII immunization. COII immunization increased tissue levels of iNOS protein and IL- 1β mRNA and protein expression, which TDZD-8 suppressed considerably (p<0.0001). Furthermore, there was a significantly (p<0.001) positive correlation between iNOS, inflammatory biomarkers, and RF. We concluded that TDZD-8 reduced RA-induced IL-1β -iNOS axis-mediated arthritis in the rat knee joint synovium. RESUMEN: La artritis reumatoide (AR), es una enfermedad autoinmune inflamatoria que causa la degradacin del cartlago y la destruccin del tejido, pudiendo afectar las articulaciones sinoviales, como la articulacin de la rodilla. No se ha estudiado el vnculo entre la xido ntrico sintasa inducible por la enzima del estrs nitrosativo (iNOS) y la citocina interleucina-1 (IL-1β) en el dao de la membrana sinovial de la articulacin de la rodilla provocado por AR con y sin la incorporacin del inhibidor de GSK3β TDZD-8. Utilizamos el mtodo de inmunizacin activa con colgeno tipo II (COII) durante veintin das para inducir AR en ratas. Se administr TDZD-8 (1 mg/kg; i.p.) diariamente a ratas inmunizadas emparejadas durante tres semanas despus del da 21 (COII+TDZD- 8). Se tomaron muestras de sangre y tejido 42 das despus de la inmunizacin. Se observ un gran aumento de los niveles sanguneos del factor reumatoideo (FR), as como un dao considerable del tejido sinovial e infiltracin de clulas inflamatorias en la membrana sinovial, para validar la aparicin de la AR despus de la inmunizacin con COII. La inmunizacin con COII aument los niveles tisulares de la protena iNOS y la expresin de protena y ARNm de IL-1β, que TDZD-8 suprimi considerablemente (p<0,0001). Adems, hubo una correlacin positiva significativa (p<0,001) entre iNOS, biomarcadores inflamatorios y FR. Concluimos que TDZD- 8 redujo la artritis mediada por el eje IL-1β-iNOS inducida por la AR en la sinovial de la articulacin de la rodilla de rata.

Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice

Adenovirus-Mediated Small Interfering RNA Targeting TAK1 Ameliorates Joint Inflammation with Collagen-Induced Arthritis in Mice

Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion

Inhibition of transforming growth factor β-activated kinase 1 prevents inflammation-related cartilage degradation in osteoarthritis

The Role of Torkinib in Inhibiting the Proliferation and Migration of Rheumatoid Arthritis Fibroblast-Like Synoviocytes

T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis

Therapeutic Treatment of a Novel Selective JAK3/JAK1/TBK1 Inhibitor, CS12192, in Rat and Mouse Models of Rheumatoid Arthritis.

Identification of HHT-9041P1: A novel potent and selective JAK1 inhibitor in a rat model of rheumatoid arthritis

Immune regulatory and anti‐resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice

Therapeutic Effect of Cryptotanshinone on Collagen-Induced Arthritis in Rats Via Inhibiting Nuclear Factor Kappa B Signaling Pathway

Tectoridin exhibits anti-rheumatoid arthritis activity through the inhibition of the inflammatory response and the MAPK pathway in vivo and in vitro

Novel Bruton's tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis

Suppression of Nitrosative Stress and Inflammation of the Knee Joint Synovium in Collagen Type II-Induced Rheumatoid Arthritis by the Inhibition of Glycogen Synthase Kinase-3ß

Theaflavin-3, 3′-Digallate Attenuates Rheumatoid Inflammation in Mice Through the Nuclear Factor-κB and MAPK Pathways

Selective inhibition of CDK7 ameliorates experimental arthritis in mice

Targeting Kinase ITK Treats Autoimmune Arthritis Via Orchestrating T Cell Differentiation and Function

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis

Tanshinone IIA Suppresses Proliferation and Inflammatory Cytokine Production of Synovial Fibroblasts from Rheumatoid Arthritis Patients Induced by TNF-α and Attenuates the Inflammatory Response in AIA Mice

Effects Of A Novel Tylophorine Analog On Collagen-Induced Arthritis Through Inhibition Of The Innate Immune Response

Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression

Treatment of collagen-induced arthritis rat model by using Notch signalling inhibitor